30.08.2014 Views

studia universitatis babeş-bolyai biologia 2

studia universitatis babeş-bolyai biologia 2

studia universitatis babeş-bolyai biologia 2

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

C. PAŞCA et al.<br />

Cisplatin (Platinol, cis-DDP) is a platinum compound belonging to the<br />

alkylating agents, successfully applied in the chemotherapy of several types of<br />

cancer. The antineoplasic activity is generally believed to result from the<br />

interaction of the drug with the DNA in the tumour cells, this interaction leading to<br />

the formation of different types of adducts through the reaction of the bifunctional<br />

platinum compound with N7 atoms of the nucleobases guanine and adenine. The<br />

major adducts are intrastrand cross-links formed by the binding of cis-DDP on two<br />

neighbouring guanines, on adenine and guanine, and on two guanines separated by<br />

one or more nucleobases. Other types of adducts formed are the interstrand crosslink<br />

on two guanines and monofunctionally bound cis-DDP. Inside cells, cis-DDP<br />

can form DNA-protein cross-links [6-8]. Cisplatin has a significant hematologic<br />

and nonhematologic toxicity, especially nephrotoxicity. The histological and<br />

ultrastructural modifications induced by this anticancer drug on the rat kidney are<br />

still incompletely known; therefore, our investigations tried to emphasise these aspects<br />

in concordance with the moment of the sacrification after the administration of<br />

some therapeutic doses.<br />

Material and methods. Our experiments were carried out with the following<br />

five groups of healthy adult male Wistar rats, weighing 190 + 10 g and maintained<br />

under bioclimatic laboratory conditions, with no food for 18 hours before the<br />

treatment, but having water ad libitum:<br />

-group U – untreated (control) group;<br />

-group C 1 , C 2 , C 3 and C 4 treated i.v. with 20 mg Cisplatin /m 2 body surface/day,<br />

for three days, and sacrificed 24 hours, 4, 11 and 18 days after the treatment.<br />

The animals were not fed for 18 hours before the sacrification. Having<br />

sacrificed the animals, we took fragments from the kidney. For microscopic<br />

examination the fragments were fixed in 10% neutral formol, processed by the<br />

paraffin technique and the sections of 6 µm were stained by the hematoxylin-eosin,<br />

Masson-Goldner trichrome and PAS methods [12]. For ultrastructural investigations<br />

fragments of kidney were prefixed in 2.7% glutaraldehyde solution and postfixed<br />

in 2% osmic acid solution. The fragments were dehydrated in acetone and then<br />

embedded in Vestopal W. The ultrathin sections were obtained using an LKB III<br />

ultramicrotome and were contrasted with uranyl acetate. Examination of the sections<br />

were performed in a TESLA-BS-500 electron microscope [1, 10, 13].<br />

On the stained and contrasted sections we studied, by light and electron<br />

microscopic examinations, the histological and ultrastructural modifications induced<br />

by this anticancer drug in concordance with the moment of the sacrification.<br />

Results and discussion. The light and electron microscopy investigations<br />

of the kidney sections showed the appearance of some significant modifications<br />

which seemed to be in concordance with the moment of the sacrification.<br />

58

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!